Central nervous system (CNS) tissues contain cells (i.e. glia and neurons) that have innate immune functions. These cells express a range of receptors that are capable of detecting and clearing apoptotic cells and regulating inflammatory responses. Phagocytosis of apoptotic cells is a nonphlogistic (i.e. noninflammatory) process that provides immune regulation through anti-inflammatory cytokines and regulatory T cells. Neurons and glia express cellular death signals, including CD95Fas/CD95L, FasL, tumor necrosis factorYrelated apoptosisinducing ligand (TRAIL) and tumor necrosis factor receptor 1 (TNFR), through which they can trigger apoptosis in T cells and other infiltrating cells. Microglia, astrocytes, ependymal cells, and neurons express defense collagens and scavenger and phagocytic receptors that recognize apoptotic cells displaying apoptotic cell-associated molecular patterns, which serve as markers of Baltered self.[ Glia also express pentraxins and complement proteins (C1q, C3b, and iC3b) that opsonize apoptotic cells, making them targets for the phagocytic receptors CR3 and CR4. Immunoregulatory molecules such as the complement regulator CD46 are lost from apoptotic cells and stimulate phagocytosis, whereas the expression of CD47 and CD200 is upregulated during apoptosis; this inhibits proinflammatory microglial cytokine expression, thereby reducing the severity of inflammation. This review outlines the cellular pathways used for the detection and phagocytosis of apoptotic cells in vitro and in experimental models of CNS inflammation.
INTRODUCTION
The systemic organs rely upon the adaptive immune system to detect and clear pathogens and toxic cell debris after ischemia, infection, and other types of injury (1) . The central nervous system (CNS) differs from systemic organs because it is segregated from the systemic circulation by the blood-brain barrier; under normal conditions, this excludes the cells of the adaptive immune system (e.g. neutrophils dendritic cells, macrophages, and natural killer cells) from providing the same extent of immune surveillance of the CNS that they do in other tissues (2) . Instead, the CNS relies upon resident glia (i.e. microglia, astrocytes, and ependymal cells), neurons, perivascular cells, and choroid plexus cells to provide innate immune responses that are capable of differentiating between Bself[ host and Bnonself[ pathogens (3Y5).
Glia, choroid plexus cells, and neurons express highly conserved pattern recognition receptors (PRRs) that, together with the defense collagens and opsonins (including complement), provide the capability for detecting and phagocytosing nonself pathogens (4, 5) . Pattern recognition receptors detect nonself unique carbohydrate structures (lipopolysaccharides and peptidoglycans) that are termed Bpathogen-associated molecular patterns[ (PAMPs) and are found exclusively in the cell walls of pathogens. Scavenger receptors are a class of PRRs that preferentially detect modified lipoproteins (1, 4, 6) .
The active destruction of infiltrating T cells and injured neurons through apoptosis contributes to CNS immune surveillance and downregulation of inflammation (7Y9). Apoptotic cells contain potentially neurotoxic proteins and cytokines; therefore, they must be rapidly detected and cleared before they increase the severity of tissue injury. Cells undergoing apoptosis express cell surface apoptotic cellYassociated molecular patterns (ACAMPs) that are similar to PAMPs and act as Beat me[ signals; these are recognized by PRRs and soluble defense molecules of the CNS innate immune system ( Fig. 1 ) (4Y6, 10). Thus, the CNS innate immune system has multiple roles, as the initiators of apoptosis in injured and infiltrating inflammatory cells and the rapid removal of apoptotic cells from the CNS as a protection from further injury (11) . The failure to clear apoptotic cells from the CNS results in their accumulation in ischemic infarction, bacterial meningitis, viral encephalitis, and neurodegenerative diseases (12Y14). The presence and roles of apoptotic cells in multiple sclerosis (MS) lesions are presently unclear, but there is strong evidence for apoptosis in experimental autoimmune encephalomyelitis (EAE), an animal model of MS (8, 9, 15Y17) .
This review describes how the CNS innate immune system initiates apoptosis of damaged and infiltrating cells and how these apoptotic cells are distinguished from host cells, allowing them to be cleared rapidly from the CNS, thereby maintaining tissue homeostasis and promoting tissue repair. associated with rapid injury and results in the disintegration of the cell and the release of its contents into the surrounding tissue (18, 19) . Secondary necrosis applies to apoptotic cells that have disintegrated before they are cleared by phagocytes, usually when the number of apoptotic cells exceeds the capacity of the host tissue to remove them, such as in CNS inflammation with large numbers of infiltrating T cells undergoing apoptosis. Apoptosis or type 1 programmed cell death must also be distinguished from type II programmed cell death, termed Bautophagy,[ which is literally Bselfeating.[ This mechanism relies upon the lysosomal machinery of the cell to destroy its membrane-bound organelles (20) . Apoptosis is identified by the ultrastructural features of blebbing of the cell membrane and the condensation of nuclear chromatin together with the formation of chromosomal DNA fragments into 180 to 200 base pairs that produce a laddering effect with gel electrophoresis. Terminal transferase-mediated dUTP nick end labeling staining is widely used to detect double strand DNA breaks as an indicator of apoptosis, but this method also detects single strand DNA breaks associated with necrosis (21Y23). According to Savill et al (24) , the critical feature to identify apoptosis in vivo is phagocytosis of either whole cell or membrane-bound apoptotic bodies.
Apoptosis is initiated by the activation of intracellular cysteine-dependant aspartate-specific proteases (caspases); caspases are homologous to the nematode CED-3 gene product that mediates cell death in Caenorhabditis elegans (25, 26) . There are 14 individual caspases, 11 of which are present in humans; they are divided into upstream regulators and downstream executioners (14, 25) . The upstream components such as caspase 8 are activated by several cytokines, CD95/CD95L and tumor necrosis factor receptor (TNFR); these are regarded as Bdeath signals[ that subsequently activate downstream caspases that initiate apoptosis and DNA fragmentation (14, 26, 27) . The caspases are also regulated at the transcriptional level in neurodegenerative diseases such as Huntington disease, Alzheimer disease (AD), motor neuron disease, and in acute neurologic diseases such as ischemic stroke and bacterial meningitis; all of these conditions are characterized by the presence of apoptotic cells (12Y14, 23, 28, 29) .
Why the Initiation and Clearance of Apoptotic Cells Are Essential to Limit CNS Injury
As previously indicated, the innate immune system is capable of rapidly detecting and clearing apoptotic cells from the CNS and regulating inflammation and limiting tissue damage under normal conditions (5, 7, 8) . The induction of apoptosis in T cells, virus-infected cells, and injured neurons renders potentially infected and damaged cells Bsafe[ only if the apoptotic cells are rapidly cleared from the area of inflammation and cell injury by the innate immune system. If apoptotic cells accumulate within CNS tissue, they undergo secondary necrosis and release their toxic contents, thereby increasing tissue destruction (24) . The active induction of apoptosis in T cells and other systemic inflammatory cells by death signals transforms potentially dangerous inflammatory cells and damaged neurons into safe targets and provides the CNS with a degree of immune surveillance and the capacity to regulate the severity of inflammation and remove damaged cells (7Y9).
Innate Immune System Expresses Death Signals That Initiate Apoptosis
Glia and neurons express molecules that are capable of acting as death signaling pathways; these are members of the TNF superfamily and include CD95 (Fas)/CD95L (Fas L), TNFYTNFR-1, and TNF-related apoptosis-inducing ligand (TRAIL) and two perforins (Fig. 2) (27, 30Y34) . The natural ligand of CD95/Fas is CD95L/Fas L; both are expressed by glia and neurons and other cells in tissues that maintain an immune privileged status such as the eye and testis (33, 34) . In EAE induced by passive transfer of T-cell receptor VA 8.2+ myelin basic proteinYspecific T cells, most apoptotic T cells were found to be from the VA 8.2+ T-cell clone; they expressed CD95/CD95L and were present in the recovery phase of the disease (7Y9). The VA 8.2+ T cells that expressed CD95 were more vulnerable to apoptosis than those that did not, suggesting that the ligation of CD95 by CD95L triggers T-cell apoptosis in EAE (7, 8, 35) . Moreover, administration of anti-CD95 antibody to Lewis rats with EAE in the clinical recovery phase reduced T-cell apoptosis, increased inflammation, and delayed functional recovery (36) . Motor neurons express CD95/FasL, and after injection of a Fas + CD4 T-cell line into rats with facial nerve axotomy, T-cell apoptosis was increased, but there was a reduction in motor neuron apoptosis (37) . The CD95 death signal pathway is also responsible for triggering neuronal apoptosis in ischemic neurons, transforming them into suitable safe targets for phagocytic clearance (38) . The CD95/CD95L pathway is elevated on glia and neurons in AD, Huntington disease, motor neuron disease, MS, viral and bacterial meningitis, and cerebral infarcts; this correlates with initiation of apoptosis in these conditions (32) .
The TNF<TNFR Death Signaling Pathway in EAE Triggers Apoptosis Independently of CD95/CD95L Fas/FasL
Tumor necrosis factor binds to membrane receptor TNFR-1; this in turn recruits TNFR-1Yassociated death domain protein, which activates the intracellular caspase pathway resulting in apoptosis (39) . Compared with the CD95/ CD95L pathway and its role as an inflammatory signaling pathway, TNF-induced apoptosis is relatively minor (40) . Nevertheless, TNF has proapoptotic death signal properties as indicated by reduced T-cell apoptosis in TNFR-1Ydeficient mice with EAE. Similarly, the administration of anti-TNF Copyright @ 2009 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited.
antibodies in EAE also has been shown to reduce T-cell apoptosis (31, 41) .
The TNF-Related Apoptosis-Inducing Ligand Death Pathways
Tumor necrosis factorYrelated apoptosis-inducing ligand (TRAIL), a member of the TNF/Nerve growth factor superfamily, is not expressed under normal conditions in the CNS but is upregulated in brain inflammation and functions as a potential death signal that can initiate apoptosis (42) . Four TNF-related apoptosis-inducing ligand receptors have been identified, and receptor 2 is expressed by neurons, astrocytes, and oligodendrocytes in the human brain; this receptor can induce caspase-related apoptosis. This pathway has not been found to contribute to T-cell elimination from the CNS, however, and its role in regulating inflammation and apoptosis is not yet clear (32, 40, 42) .
Apoptotic Cells Express ACAMPs to Promote Their Clearance From the CNS
Host cells are identified as self, but after apoptosis, they become transformed into Baltered self[ and express ACAMPs; that is, Beat me[ signals that promote their rapid clearance by phagocytic cells ( Fig. 1) (1, 4, 6). The most widely recognized ACAMP is the highly conserved lipid phosphatidylserine (PS), which is located on the inner plasma membrane. During apoptosis, PS remains exposed on the outer membrane due to the inhibition of aminophospholipid translocase by scramblase, a process that is caspase-dependent (43Y46). One method of identifying apoptotic cells is Annexin V staining, which detects PS located on the outer membrane (45) . Phosphatidylserine is recognized by the phosphatidylserine receptor (PSR) and by the soluble bridging molecules, milk fat globule, A2-glycoprotein 1, and the product of the growtharrestYspecific gene 6 (24, 43, 44, 47, 48) . These bridging molecules link PS with >vA3 vitronectin, A2-glycoprotein 1, and Mer receptors, respectively, which are expressed on the surfaces of phagocytic cells (24) . The PSR also binds to complement components deposited on the surface of apoptotic cells and may share a binding site with Annexin V (49). Thrombospondin (TSP) acts as a bridging molecule between an apoptotic cell surface and the >vA3 integrin vitronectin receptor, and CD36 receptor on phagocytes (24) . Apoptotic cellYassociated molecular patterns also include the surface adhesion molecule intercellular adhesion molecule 3 (SCAN-3) on leukocytes, the loss of sialic acid residues from carbohydrates in the apoptotic cell wall, and the presence of oxidized low-density lipoprotein-like sites (50, 51) .
The CNS Innate Immune System Expresses a Range of Receptors That Is Capable of Detecting ACAMPs and Phagocytosing Apoptotic Cells
The macrophage >vA3 integrin vitronectin receptor was the first receptor identified that initiates phagocytosis of apoptotic cells in vitro (52) , but the range of pattern recognition receptors capable of detecting Beat me[ signals or ACAMPs has expanded. Glia and neurons express several PRRs, including mannose receptor, the class A and B scavenger receptors, CD14, and CD36, CD91, and triggering receptor expressed by myeloid cells (TREM-2) (53Y59). The expression of PRRs in the CNS is well documented especially with respect to phagocytosis of amyloid AA 4 in AD; less is known regarding the recognition of apoptotic cells by PRRs (60) .
Multiple Pattern Recognition Receptors Are Involved in Clearance of Apoptotic Cells From the CNS
CD14 is both a membrane-anchored PRR and a soluble molecule with important roles as a receptor for pathogen components, including lipopolysaccharide, apoptotic cells, and neurotoxic proteins such as amyloid AA 4 (54, 55, 61) . CD14 is expressed by microglia and interacts with apoptotic lymphocytes via the intercellular adhesion molecule intercellular adhesion molecule 3 (54) . In vitro, CD14 is a macrophage PRR for both ACAMPs and PAMPs, using a common domain on the same receptor. The clearance of apoptotic cells by CD14 is anti-inflammatory, and the soluble form of CD14 binds to and switches off activated T cells. In contrast, its interaction with lipopolysaccharide is proinflammatory (10, 54) . Apoptotic cells accumulate in CD14-deficient mice, but there is no evidence of an autoimmune disease in them, possibly because of the immunosuppressive effect of the anti-inflammatory cytokine transforming growth factor A (TGF-A) (62, 63) .
CD36, a Scavenger Receptor
There are 2 main classes of scavenger receptors; both are highly conserved and expressed on macrophages and microglia (61, 64) . Class A consists of SR-AI and SR-AII; class B includes CD36. The latter receptor can bind to PS and oxidized low-density lipoprotein-like sites present on apoptotic cell surfaces and to neurotoxic proteins such as amyloid AA4 (53, 57, 65, 66) . Macrophage CD36 cooperates with the vitronectin avA3 integrin receptor (CD51/CD61) to increase phagocytosis of apoptotic cells; they both recognize the bridging protein TSP, which locates on the surface of cells undergoing apoptosis (24, 53, 61, 67) . Thrombospondin is expressed by glia and smooth muscle cells and functions as a molecular bridge connecting macrophages to apoptotic cells. The ligand that TSP recognizes on the apoptotic cell surface has not yet been identified (24, 68) .
CD91 (>2 Macroglobulin or LRP Low-Density Lipoprotein Receptor)
CD91 is expressed by microglia and binds to amyloid AA 4 and apolipoprotein E, as well as to apoptotic cells (53) . Macrophages deficient in apolipoprotein E fail to phagocytose apoptotic cells, and this is associated with an increase in the expression of proinflammatory cytokines (69) . CD91 also recognizes calreticulin, a soluble protein located on the endoplasmic reticulum, which during cell apoptosis migrates to the cell surface and is a potentially important ligand for several phagocytic receptors (45, 58, 69) . The collectins (mannose-binding lectin [MBL] and C1q) are pattern recognition receptors that are capable of detecting apoptotic cells and promoting clearance because they bind to calcireticulin and the macrophage CD91 complex (58, 70, 71) .
Triggering Receptor Expressed by Myeloid Cells 2 (TREM-2)
Triggering receptor expressed by myeloid cells 2 is a scavenger receptor expressed on monocyte-derived dendritic cells, osteoclasts, and microglia. In vitro, microglia that express TREM-2 demonstrated increased phagocytosis of membrane fragments from apoptotic neurons. Moreover, intravenous administration of TREM-2 in bone marrow precursor cells in vivo was accompanied by downregulation of TNF, increased interleukin 10 expression, and greater clearance of myelin debris; these had the effect of reducing the severity of EAE (59).
CR3 CR4 A Integrin Receptors
Microglia express the A integrin receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) that identify apoptotic cells opsonized with complement opsonins C3b and iC3b (4, 5, 72Y74). iC3b increases on apoptotic cells as the result of classical complement pathway activation by PS (49) . Human microglia, ependymal, and choroid plexus cells all express CR3 and CR4 and are capable of clearing apoptotic cells from the brain, cerebrospinal fluid, and ventricular surfaces (74) .
Phosphatidylserine Receptor (PSR)
Phosphatidylserine receptor expressed by glia and neurons recognizes the ACAMP PS on the outer cell membrane of apoptotic cells (75, 76) . Hoffman et al (77) showed that PS induces PSR-related macropinocytosis and clearance of apoptotic cells. Proteomic studies have found an engulfment protein annexin 1 colocalized with PS on the cell membrane; the downregulation of this protein prevented apoptotic cell removal in vivo, thereby reducing the effectiveness of PSR as a clearance receptor (78).
Phagocytosis of Apoptotic Cells Involves Several Stages
Phagocytosis of apoptotic cells involves recognition and contact, followed by subsequent engulfment through macropinocytosis, a sequence of steps described as Btether and tickle [ (46) . The phagocyte receptors CD14, CD36, integrins, and the bridging molecule TSP produce Btethering,[ but the inclusion of PS promotes uptake, although by itself, the avidity of PS is too low to promote engulfment on its own (24, 43, 44) . After tethering, the apoptotic cell contacts the postulated corpse recognition and engulfment complex that contains various signaling proteins that initiate engulfment and anti-inflammatory response (45) . The identity of the receptors and ligands responsible for engulfment is not clear, but PS binds to C1q and the calreticulin (C1qR)/CD91 complex (60, 72, 79, 80) . Calreticulin is increased on the surface of an apoptotic cell and can either bind to CD91 directly or through a collectin (C1q, MBL, or surfactant protein A) already attached to the apoptotic cell (71) . Phagocytes bind to apoptotic cells because CD31 changes its normal function to act as an attachment signal promoting engulfment of apoptotic cells (81) .
Following mutation studies in C. elegans, several pathways controlling apoptotic cell corpse recognition and engulfment have been identified (25) . One of these pathways consists of proteins encoded by the genes CED-2, CED-5, and CED-10. The proteins encoded by these genes are homologous with the mammalian molecules CrkII, DOCK, Rho, GTPase, and Rac1 s, which have been shown to be responsible for cytoskeletal changes that precede the engulfment of apoptotic cells (24, 25, 43, 46 ). An engulfment ligand, annexin 1, is recruited to PS-rich areas on the apoptotic cell surface and promotes the clustering of macrophage PSR, enhancing the engulfment of apoptotic cells. Silencing annexin 1 only partially prevented engulfment, thereby confirming that it is one of many engulfment signals on the phagocyte cell surface (78) . These highly conserved proteins that are responsible for engulfment of apoptotic cells and their subsequent clearance clearly represent potential therapeutic targets in the CNS.
Phagocytosis of Apoptotic Cells Regulates CNS Inflammation by Expression of Anti-and Proinflammatory Cytokines
The phagocytosis of apoptotic cells is closely linked to the downregulation of inflammatory cytokines and increased capacity to promote the resolution of inflammation, which results in a nonphlogistic response and contributes to CNS immune privilege (24, 45, 82, 83) . Several in vitro studies have shown that phagocytosis of apoptotic cells released anti-inflammatory cytokines, including TGF-A, prostaglandin E2, PAF, and interleukin 10 and tissue growth factors such as vascular endothelial growth factor; these are all capable of reducing tissue inflammation and promoting tissue repair (84Y87). Interestingly, TSP and the >v integrins both tether apoptotic cells, resulting in the release and activation of TGF-A from phagocytic cells (63) . The anti-inflammatory cytokines inhibit the synthesis of the proinflammatory cytokines such as TNF, prostaglandins, nitric oxide, and eicosanoids from macrophages, thereby adding to the protective effect of phagocytosing apoptotic cells and reducing the inflammatory response (88) . The administration of anti-CD3 antibody to mice also produced an increase in both T-cell apoptosis and the expression of TGF-A by macrophages. In vitro, immature dendritic cells exposed to apoptotic T cells increased TGF-A expression and the formation of CD4 + Foxp3 + regulatory T cells, whereas in vivo, the depletion of macrophages reduced the beneficial effects of administering anti-CD3 to mice with EAE. This increased the severity of the inflammation due to a significant reduction in both TGF-A and regulatory T cells because CNS macrophages were not available to phagocytose apoptotic cells (89) .
Although apoptosis is nonphlogistic, the early stages of apoptosis can be associated with an increased expression of CD95, TNF, and other proinflammatory cytokines (90) . One explanation for this proinflammatory response during the first stages of apoptosis is that it recruits sufficient numbers of phagocytes to the site of inflammation through the release of a phospholipid chemoattractant, thereby promoting rapid clearance of apoptotic cells before they undergo secondary necrosis (62, 91) .
Soluble Molecules Expressed by Glia Detect ACAMPs and Promote Their Clearance
The CNS innate immune system expresses defense collagens that contribute to immune regulation because they are able to recognize nonself PAMPs and altered self-ACAMPs on apoptotic cells. They function as bridge molecules between the apoptotic cell and phagocytic receptors expressed on neurons and glia (4, 70) .
Defense Collagens (MBL and Surfactant Protein A)
Defense collagens are a family of highly conserved soluble molecules expressed by the liver, lungs, and astrocytes (92, 93) , including MBL and lung surfactant protein A. Both of these collectins can recognize carbohydrate patterns containing mannose and fucose in PAMPs as found in bacterial cell walls (i.e. nonself) but do not recognize self patterns expressed by mammalian cells (4, 70) . The globular carboxyl terminal of the defense collagen acts as PRR recognizes PAMPs and potentially ACAMPs, whereas the N-terminal domain links defense collagen to a receptor on microglia or phagocyte. Surfactant protein A and MBL are capable of binding to apoptotic cells and neutrophils, both acting as bridging molecules between the apoptotic cell and phagocyte receptor CD91 (59, 84, 94) .
Pentraxins
The pentraxins are highly conserved proteins with a cyclic multimeric structure and include the acute-phase reactant C protein and serum amyloid protein. Microglia and neurons express acute-phase reactant C protein and serum amyloid protein, both of which are capable of opsonizing apoptotic cells with subsequent binding to the collectin C1q to stimulate phagocytosis (4, 95) . Acute-phase reactant C protein recognizes apoptotic cells and oxidized low-density lipoprotein through binding to phosphorylcholine found in oxidized lipids, which are regarded as ACAMPs (96) . Pentraxins as opsonins also initiate phagocytosis of apoptotic cells because they are capable of binding directly to microglial immunoglobulin (FcFR) receptors and C1q (95, 96) . Despite this evidence, the contribution of the pentraxins to the removal of apoptotic cells from the CNS is yet to be defined (97) .
The Complement System Is a Vital Component of the CNS Innate Immune System for the Identification and Clearance of Apoptotic Cells
The complement system (C) consists of approximately 30 fluid-phase and cell membrane proteins that are essential components of the CNS innate immune system. Microglia, astrocytes, ependymal cells, oligodendroglia, and neurons can synthesize the full range of C components (98, 99) . Three C pathways (i.e. the classical, alternative, and lectin) have been identified. The classical pathway is activated by the first component C1q binding to a wide range of ligands, including apoptotic cells, with the formation of the opsonins C3 and C4 and chemoattractant anaphylatoxins C3a and C5a; both increase the efficiency of phagocytosis (49, 79) .
The C pathway is important for apoptotic cell clearance because in C1q-deficient mice, apoptotic cells accumulate in the kidney, resulting in a glomerulonephritis with immune deposits (100) . Furthermore, individuals with C1q deficiency develop a systemic lupus erythematosus-like disease because impaired apoptotic cell clearance results in the accumulation of potential autoantigens such as DNA, RNA, and caspases that trigger inflammatory autoimmune responses (101, 102) . The close relationship between apoptosis and the innate immune system is highlighted by the activation of the complement system by PS on apoptotic cell membranes, generating the opsonin iC3b and increasing uptake of apoptotic cells by the A2 integrin receptors (CR3, CR4) (49) . C1q can bind to blebs on the surface of apoptotic keratinocytes to induce C activation and the generation of opsonins to promote phagocytosis (103, 104) .
C1q and Complement Opsonins That Detect ACAMPs and Promote Clearance
C1q has a multimeric structure capable of detecting the presence of apoptotic cells and a wide range of toxic ligands (e.g. PS, DNA, myelin, hypoxic neurons, and immune complexes) that activate the C system (4, 71, 80, 100). The injection of C1q into the peritoneal cavity of C1q j/j mice increased the uptake of apoptotic cells compared with control animals; knockout experiments involving C3and C4 also showed that different components of the classical pathway are important for apoptotic cell clearance (102) .
The identity of the C1q receptor is not entirely clear; 1 candidate is C1qRp, an analog of the stem cell marker AA4 (renamed CD93) expressed by microglia, endothelial cells, and neurons (105, 106) . Although the interaction between C1q and C1qRp increases microglial phagocytosis, its specificity has been challenged (107) . The highly conserved PS expressed on apoptotic cells and IgM both bind to C1q, and this activates the classical C pathways generating the C opsonins C3b and iC3b (80, 108) . These 2 C opsonins bind covalently to apoptotic cells, making them targets for the A integrin (CR3 and CR4) receptors expressed by microglia and choroid plexus (74) . C3b is present on damaged neurons in the striatum of Huntington disease and has been associated with activated microglia that express both CR3 and CR4 receptors (109) . Activated microglia and the Kolmer cells in the choroid plexus express CR3 and CR4, whereas CR1 (CD35) is expressed by astrocytes (74) . These receptors bind to C1q, C3b, and iC3b, as well as to MBL, thereby emphasizing the importance of glia for removing C opsonized apoptotic cells from the CNS and cerebrospinal fluid (49, 64, 73) .
The Loss of ''Don't Eat Me'' Signals Helps Identify Apoptotic Cells and Regulate the Severity of Inflammation
Glia and neurons express a range of self-defense molecules termed Bdon't eat me[ signals or self-associated molecular patterns (SAMPs) that bind with PRRs expressed on microglia, thereby inhibiting autoimmune responses (1, 4, 5) . The loss of a Bdon't eat me[ signal during apoptosis renders a cell susceptible to attack from local phagocytes, resulting in increasing inflammation and tissue destruction (110) . An example of this paradigm is the expression of the selfdefining Bdon't eat me[ signal major histocompatibility Copyright @ 2009 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited.
complex type I (MHC-1)molecules by host cells to avoid detection by natural killer cells. The absence of major histocompatibility complex type I molecules due to infection or apoptosis provides the stimulus for natural killer cells to attack (111) . To avoid self-destruction and phagocytosis, many cells express SAMPs; these include the presence of sialic acid on the cell surface and the complement regulators (e.g. Factor H, CD55, CD46) together with the immunoregulatory molecules CD200 and CD47 (4, 5) . These SAMPs are all downregulated during apoptosis, thereby creating an altered self with loss of inhibition of local microglia and an increased inflammatory response. Because CD55 is a ligand for CD97 on macrophages, the CD55-CD97 interaction might regulate phagocytosis of apoptotic cells (112) . The endothelial molecule CD31 provides a detachment signal (i.e. don't eat me) to prevent phagocytosis of normal cells. During apoptosis, however, rather than downregulating CD31, changes its function to a proadhesive signal (eat me), thereby promoting ingestion of apoptotic cells and their clearance (81) .
CD46 Is A SAMP ''Don't Eat Me'' Signal and Complement Regulator that Is Lost During Apoptosis
Microglia, astrocytes, oligodendroglia, and neurons all express complement regulators, including CD46 (99, 113) . In numerous apoptotic cell lines, CD46 was released from the surface of apoptotic cells in the form of blebs that increase the surface accumulation of C3b, thereby making the cell a target for phagocytosis (113) . CD46 represents a Bdon't eat me[ signal similar to CD31and major histocompatibility complex type I; therefore, the presence of CD46 on neurons and glia inhibits their phagocytosis by microglia. The downregulation of complement regulators, including CD46, however, leaves the apoptotic cell vulnerable to C attack, thereby increasing tissue damage by the release of inflammatory cytokines (79) . To prevent excessive C activation during the later stages of apoptosis, apoptotic cells acquire the C inhibitor C4b-binding protein that binds to apoptotic cells via PS and prevents the attack of vulnerable apoptotic cells against further complement activation and lysis (114) . The C4b-binding protein binds to amyloid AA 1-42 peptide and apoptotic, but not viable, cells in AD, limiting the extent of C activation in the brain (115) . Complement regulators, therefore, have different roles, either as a Bdon't eat me[ marker on viable cells preventing their clearance or in the later stages of apoptosis in preventing excessive C activation of vulnerable apoptotic cells that would increase the severity of tissue inflammation (4, 5, 79, 113) .
CD47 and Its Counterreceptors CD172 and TSP
The integrin CD47 has 2 counterreceptors, CD172 and TSP, which are responsible for the regulation of CNS inflammation and initiation of apoptosis, respectively (116, 117) . CD47 is expressed by astrocytes, endothelial cells, and neurons, whereas the counterreceptor, a plasma membrane protein (CD172a), is present on microglia and neurons but not on astrocytes (118) . The interaction between CD47 and CD172a results in the downregulation of microglial phagocytosis, the prevention of neutrophils migrating across the blood-brain barrier, increased expression of TGF-A, and decreased interferon >, all reducing the inflammatory response (117Y119).
The interaction between CD47 and TSP promotes apoptosis and limits inflammation by regulating the numbers of activated T cells (116) . Furthermore, CD47 functions as a Bdon't eat me[ signal because cells deficient in CD47 are rapidly removed from the circulation by the spleen, thereby preventing inappropriate phagocytosis of host cells (120, 121) . Apoptotic cells rapidly lose CD47, which reduces their ability to bind and phosphorylate CD172a, thereby increasing clearance through phagocytosis (120) . The presence of CD47 on neurons and T cells, however, is also capable of promoting apoptosis through the CD95/Fas-and the caspaseindependent apoptotic pathways (120, 122) . In MS, CD47, but not CD172a expression, was reduced at the edge of chronic active lesions, contributing to the loss of immune regulation of microglia and progression of the disease (123) .
Microglia, astrocytes, and smooth muscle cells all express TSP, which is a bridging molecule between apoptotic cells and integrins on the phagocyte (24, 124) . Thrombospondin binds with CD47, and this interaction promotes apoptosis, but only of activated T cells; in doing so, TSP regulates their numbers and terminates the inflammatory response (116) . As a Bdon't eat me[ signal, CD47 inhibits phagocytosis of host cells and triggers apoptosis of activated T cells, terminating inflammation and providing an important immune regulator of CNS apoptosis and inflammation.
CD200 Is Increased During Apoptosis and Functions as an Immune Regulator
CD200 is a 41-to 47-kDa surface molecule and a member of the immunoglobulin gene superfamily characterized by 2 immunoglobulin superfamily domains, a characteristic of immunoregulatory molecules (125) . CD200 is expressed by vascular endothelium, cerebellar, and retinal neurons, whereas astrocytes generally do not express CD200 (125Y127). Microglia express the CD200 counterreceptor CD200R, and the interaction with CD200 reduces microglial activity and provides immune regulation of CNS inflammation (127) . Therefore, CD200 is another CNS-related Bdon't eat me signal,[ which has been shown to be reduced in MS tissue lesions, thereby relating to a possible loss of immune regulation of the inflammatory response (4, 5, 123) . During apoptosis, CD200 is under the control of both caspase-and p53-dependent pathways that increase CD200 expression on apoptotic cells. The presence of upregulated CD200 inhibited proinflammatory cytokine expression from apoptotic dendritic cells in vitro and promoted tolerance of autoantigens and reduction of tissue damage through its interaction with CD200R (128) .
CONCLUSION
The brain is situated behind the blood-brain barrier and is isolated from the adaptive immune system. Resident cells participate in the innate immune system by initiating apoptosis of damaged and infected cells and facilitating removal of apoptotic cells from the CNS. Apoptotic cell death in the CNS is triggered by death signaling pathways that are expressed by
